|
Aug 13
|
Kamada (KMDA) Q2 Earnings Top Estimates
|
|
Aug 12
|
Coya Therapeutics, Inc. (COYA) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 8
|
Top Midday Stories: Trade Desk CEO Says Tariffs Impacting Key Clients; UK Regulator Approves Boeing's Acquisition of Spirit AeroSystems
|
|
Aug 8
|
GSK to Receive $370 Million From CureVac, BioNTech Patent Dispute Settlement
|
|
Aug 8
|
Trending tickers: Nvidia, Intel, The Trade Desk, Pinterest and GSK
|
|
Aug 8
|
GSK to Receive $370 Million in U.S. Patent Litigation Settlement
|
|
Aug 7
|
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 5
|
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 4
|
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
|
|
Jun 20
|
CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech
|
|
Jun 13
|
Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz
|
|
Jun 12
|
Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop
|
|
Jun 12
|
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
|
|
Jun 12
|
Gold prices, BioNTech to acquire CureVac, Tapestry upgrade
|
|
Jun 12
|
Top Stock Movers Now: Oracle, Boeing, CureVac, and More
|
|
Jun 12
|
Top Midday Stories: Boeing Shares Fall After Air India Plane Crash; Oracle Q4 Results Top Expectations
|
|
Jun 12
|
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
|
|
Jun 12
|
BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business
|
|
Jun 12
|
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Deal
|
|
Jun 12
|
BioNTech buys mRNA, courtroom rival CureVac in all-stock deal
|